Limited public awareness about the potential of psychedelic microdosing.
Skepticism and stigma surrounding psychedelic medicine.
Desire to secure partnerships and funding for ongoing research.
Raise Awareness: Increase public understanding of the potential benefits of psychedelic microdosing.
Combat Stigma: Address and reduce skepticism and stigma surrounding psychedelic medicine.
Secure Support: Gain partnerships and funding to further their research and development efforts.
Research & Strategy Development:
Conducted thorough market research to understand public perception.
Developed a comprehensive PR strategy focused on education and engagement.
Content Creation & Distribution:
Crafted compelling press releases, articles, and social media content highlighting clinical trial data.
Distributed content through targeted media outlets and influencers in the healthcare and science sectors.
Media Outreach & Engagement:
Established relationships with key journalists and media platforms.
Organized virtual press briefings and Q&A sessions with MindBio’s experts.
Monitoring & Optimization:
Monitored coverage and social media engagement to measure impact.
Adjusted strategies based on real-time feedback and analytics.
Strategic Partnership Development: Established key media partnerships to ensure consistent and widespread coverage, providing additional value to sponsors through exclusive media opportunities.
Educational Campaigns: Launched educational campaigns to inform the public about the benefits and safety of psychedelic microdosing, using engaging and accessible content.
Influencer Collaborations: Partnered with influential figures in mental health and psychedelic medicine to broaden reach and enhance credibility.
Across online, offline, and social media platforms.
From our press coverage.
Reached across various outlets.
Average authority of platform that published content.
Explore how we can help you achieve your goals and drive tangible business results.